The human macrophage cell line U937 as an in vitro model for selective evaluation of mycobacterial antigen-specific cytotoxic T-cell function

par Passmore, J S, Lukey, P T, Ress, S R
Publié 2001

Kinetics of purified protein derivative (PPD) proliferation reflects underlying suppressor mechanisms revealed by limiting dilution analysis (LDA) in patients with extrapulmonary t...

par Lukey, P T, Latouf, S E, Ress, S R
Publié 1998

Memory lymphocytes from tuberculous effusions: purified protein derivative (PPD) stimulates accelerated activation marker expression and cell cycle progression

par LUKEY, P T, LATOUF, S E, RESS, S R
Publié 1996

Benoxaprofen activates membrane-associated oxidative metabolism in human polymorphonuclear leucocytes by apparent modulation of protein kinase C.

par Lukey, P. T., Anderson, R., Dippenaar, U. H.
Publié 1988

Granule-dependent cytolysis of Mycobacterium tuberculosis-infected macrophages by human γδ+ T cells has no effect on intracellular mycobacterial viability

par Passmore, J S, Glashoff, R H, Lukey, P T, Ress, S R
Publié 2001

Reduced NK activity correlates with active disease in HIV- patients with multidrug-resistant pulmonary tuberculosis.

par Ratcliffe, L T, Lukey, P T, MacKenzie, C R, Ress, S R
Publié 1994

Changes in leucocyte and lymphocyte subsets during tuberculosis treatment; prominence of CD3(dim)CD56(+) natural killer T cells in fast treatment responders

par Veenstra, H, Baumann, R, Carroll, N M, Lukey, P T, Kidd, M, Beyers, N, Bolliger, C T, van Helden, P D, Walzl, G
Publié 2006

Immune markers measured before treatment predict outcome of intensive phase tuberculosis therapy

par Brahmbhatt, S, Black, G F, Carroll, N M, Beyers, N, Salker, F, Kidd, M, Lukey, P T, Duncan, K, van Helden, P, Walzl, G
Publié 2006